FDA Inspection
Matthew G. Davis, M.D.Matthew G. Davis, M.D. – FDA Inspection, Oct 8, 2010
Record Details
This FDA Inspection record concerns Matthew G. Davis, M.D., with an inspection on October 8, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Matthew G. Davis, M.D.
- Inspection Date
- October 8, 2010
- Product Type
- Biologics
View Company Profile
ID · 44049e16-21bb-4b0a-9e20-46dd85ae3022
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 694662
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Matthew G. Davis, M.D.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| October 10, 2025 | NAI | Bioresearch Monitoring | |
| August 9, 2024 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
| November 12, 2020 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
| March 11, 2015 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
| July 16, 2012 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Matthew G. Davis, M.D.
- FDA Inspection 1291114 - 2025-10-10
- FDA Inspection 1247057 - 2024-08-09
- FDA Inspection 1133644 - 2020-11-12
- FDA Inspection 917453 - 2015-03-11
- FDA Inspection 791266 - 2012-07-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.